BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 7457030)

  • 1. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic persistent HBsAg positive hepatitis in children. II. Effect of treatment with levamisole].
    Masi M; Paolucci P; Timoncini G; Fantini MP; Chiodo F; Franceschi C
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):471-6. PubMed ID: 310686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
    Demirci F; Bayraktaroğlu Z; Karaoğlan M; Coşkun Y; Karaoğlan I; Okan V
    Turk J Gastroenterol; 2005 Dec; 16(4):188-93. PubMed ID: 16547845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of an immunomodulator (levamisole) in HbsAg positive patients].
    Milazzo F; Ghezzi E; Resta M; Brugo MA; Vitali D; Vigevani GM; Tassi GC
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):477-84. PubMed ID: 737040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin levels in chronic post-transfusion non A non B liver disease.
    Pirotte J; Borlée-Hermans G; Boniver J; Godon JP
    Biomed Pharmacother; 1988; 42(1):55-9. PubMed ID: 3136811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of disappearance of HBs antigen from the blood serum of patients with acute hepatitis B on the level of immunoglobulins G, A and M and selected laboratory studies].
    Rzeszowska G; Patorska-Mach E; Mierzejewska I
    Pol Tyg Lek; 1979 Nov; 34(48):1862-4. PubMed ID: 530882
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of postacute viral hepatitis: the role of HBsAg.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1986; 24(1):19-22. PubMed ID: 3704499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T- and B-lymphocytes, M, A and G immunoglobulins in viral hepatitis, liver cirrhosis and HBs-Ag carrier state].
    Belozerov ES; Sagandikov BB; Shabalin VV
    Klin Med (Mosk); 1979 Mar; 57(3):63-5. PubMed ID: 312361
    [No Abstract]   [Full Text] [Related]  

  • 9. [The different biochemical course of HBsAg-negative and HBsAg-positive hepatitis (author's transl)].
    Strohm WD; Hossenfelder E; Stille W
    Z Gastroenterol; 1978 Jan; 16(1):13-23. PubMed ID: 74913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in acute viral hepatitis, chronic active hepatitis, and periarteritis nodosa (author's transl)].
    Hütteroth TH; Arnold W; Hopf U; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1978 Jun; 16(6):395-402. PubMed ID: 27909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid progression of chronic active type B hepatitis in a patient with hypogammaglobulinemia.
    Tong MJ; Nies KM; Redeker AG
    Gastroenterology; 1977 Dec; 73(6):1418-21. PubMed ID: 334624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg.
    Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T
    Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid values and immune parameters in the course of viral hepatitis in patients with alcohol abuse and without alcohol stress in anamnesis].
    Boroń P; Sokolewicz-Bobrowska E; Boroń-Kaczmarska A; Borzuchowska A; Szpakowicz T
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):270-7. PubMed ID: 6335426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of HBsAg serum level and kinetics of the level of complement as well as of IgG, IgA anf IgM in various forms of viral hepatitis of the B type].
    Loch T
    Przegl Epidemiol; 1978; 32(4):417-28. PubMed ID: 734129
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin levels in acute A, B, and non-A, non-B hepatitis.
    Zhuang H; Kaldor J; Locarnini SA; Gust ID
    Gastroenterology; 1982 Mar; 82(3):549-53. PubMed ID: 6797867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of chronic hepatitis (author's transl)].
    Auer IO
    Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin levels during acute viral B hepatitis.
    Markus R; Baumgarten R; Fengler JD
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(5):219-22. PubMed ID: 6641595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.